International

On an international scale, PhRMA is engaged in the global concerns of innovation, research and development, hoping to support the discovery of new medicines for both common conditions and rare disorders.

Subscribe to our mailing list

* indicates required

Medicare Part D Pocket Card

Statement to Physician Payments Sunshine Act Final Rule

WASHINGTON, D.C. (February 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today:

Pharmaceutical Organizations Announce Key Principles to Foster Supply Chain Security and Integrity

Washington, D.C. (January 30, 2013) The100th meeting of the National Conference of Pharmaceutical Organizations (NCPO) resolved that the member organizations will work together to help further secure the pharmaceutical supply chain.

PhRMA Special 301 Submission 2013

Hurricane Sandy Special Report

PhRMA Applauds Passage of Russia PNTR

Washington, D.C. (December 6, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today:

“We applaud Congress for approving Permanent Normal Trade Relations (PNTR) for Russia.  Improving trade relationships with Russia will protect and bolster U.S. biopharmaceutical jobs and exports.

Biopharmaceuticals in Medicare, Medicaid and Department of Veterans Affairs

PhRMA Statement on Rx Response’s Pharmacy Status Reporting Tool Activation in 11 States and the District of Columbia

Washington, D.C. (October 31, 2012)-- Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today on Rx Response activation in the wake of Hurricane Sandy:

Pages

Subscribe to RSS - Access